OFIX Stock Analysis: Buy, Sell, or Hold?
OFIX - Orthofix Medical Inc. Common Stock (DE)
$8.93
0.24 (2.76%)
▲
5d:
-4.08%
30d:
-14.13%
90d:
-3.25%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When OFIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OFIX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OFIX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.28
Based on -2.9% avg growth
INTRINSIC VALUE TODAY
$3.90
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OFIX is currently trading at $8.93, which is considered oversold relative to its 30-day fair value range of $9.27 to $10.33. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.1) compared to its historical average (19.8). At these levels, the market is pricing in 6.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OFIX is in a downtrend. Immediate support is located at $8.62, while resistance sits at $9.81.
Market Sentiment: OFIX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.00 (+45.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OFIX is in a downtrend. Immediate support is located at $8.62, while resistance sits at $9.81.
Market Sentiment: OFIX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.00 (+45.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.27 -
$10.33
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.6% below Wall St target ($13.00)
- NEUTRAL: Trading at premium valuation - market expects 6.8% growth which is achievable
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.27 -
$10.33
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$8.62
Resistance Level
$9.81
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.14
Wall Street Target
$13.00
(+45.6%)
Revenue Growth (YoY)
3.8%
Profit Margin
-7.4%
Valuation Premium vs History
+6.8% premium
PE vs Historical
24.1 vs 19.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.8%
(market-implied from PE analysis)
1-Year Target
$9.54
(+7%)
2-Year Target
$10.19
(+14%)
3-Year Target
$10.88
(+22%)
3-Yr Target (if PE normalizes)
(PE: 24→20)
PE COMPRESSION
$8.92
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.1, Growth: -9.8%)
$6.56
(+-27%)
Base:
(SPY PE: 20.2, Growth: -9.8%)
$5.48
(-39%)
Bear:
(PE: 17.1, Growth: -9.8%)
$4.66
(-48%)
Share & Embed Analysis
Last updated: September 13, 2026 6:47 AM ET
Data refreshes hourly during market hours. Next update: 7:47 AM
Data refreshes hourly during market hours. Next update: 7:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OFIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jorge Andres Cedron
SELL
3743 shares
2026-04-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
